144.6K XNAS Volume
XNAS 17 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Clay B. Thorp | Director | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 24 Feb 2025 | 15,000 | 176,141 (0%) | 0% | 0.9 | 13,800 | Common Stock |
| Ngai Hang Victor Chong | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 01 Nov 2024 | 36,500 | 100,000 (0%) | 0% | 1 | 36,500 | Common Stock |
| Ngai Hang Victor Chong | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 24 Jun 2024 | 23,500 | 63,500 (0%) | 0% | 1.1 | 24,910 | Common Stock |
| Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Nancy J. Hutson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Anthony S. Gibney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Benjamin R. Yerxa | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 15 May 2024 | 7,813 | 17,957 (0%) | 0% | 1.3 | 10,235 | Common Stock |
| Anthony Gibney | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 17 Apr 2024 | 93,290 | 100,000 (0%) | 0% | 1.3 | 121,277 | Common Stock |
| Anthony Gibney | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 17 Apr 2024 | 6,710 | 6,710 (0%) | 0% | 1.3 | 8,388 | Common Stock |
| Anthony Gibney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Ngai Hang Victor Chong | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 20 Mar 2024 | 30,000 | 30,000 (0%) | 0% | 1.6 | 48,000 | Common Stock |
| Ngai Hang Victor Chong | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Lasezkay M. George | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 439,500 | 439,500 | - | - | Employee Stock Option (right to buy) | |
| Deignan Charles A. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 18 Jan 2024 | 12,900 | 384,662 (0%) | 0% | 1.3 | 16,512 | Common Stock |
| A. Deignan Charles | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Lasezkay M. George | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 18 Jan 2024 | 18,000 | 466,577 (1%) | 0% | 1.3 | 22,860 | Common Stock |
| Thomas Ciulla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.62 per share. | 10 Jan 2023 | 2,170 | 305,590 (0%) | 0% | 1.6 | 3,515 | Common Stock |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 487,500 | 487,500 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 187,500 | 187,500 | - | - | Employee Stock Option (right to buy) | |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.25 per share. | 04 Jan 2023 | 5,000 | 302,760 (0%) | 0% | 1.3 | 6,250 | Common Stock |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 04 Jan 2023 | 5,000 | 307,760 (0%) | 0% | 1.0 | 4,750 | Common Stock |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 187,500 | 187,500 | - | - | Employee Stock Option (right to buy) | |
| Clay B. Thorp | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 21 Dec 2022 | 14,000 | 30,522 (0%) | 0% | 1.0 | 14,266 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 23,636 | 0 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. | 20 Dec 2022 | 23,636 | 377,502 (0%) | 0% | 0.4 | 9,454 | Common Stock |
| Clay B. Thorp | Director | Other type of transaction at price $ 0.00 per share. | 15 Dec 2022 | 1,406,507 | 3,545,040 (7%) | 3% | 0 | Common Stock | |
| Clay B. Thorp | Director | Other type of transaction at price $ 0.00 per share. | 15 Dec 2022 | 8,522 | 16,522 (0%) | 0% | 0 | Common Stock | |
| Nancy J. Hutson | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 17 Nov 2022 | 30,000 | 83,000 (0%) | 0% | 1.3 | 39,900 | Common Stock |
| Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Nancy J. Hutson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.12 per share. | 18 Jan 2022 | 10,800 | 504,607 (1%) | 0% | 2.1 | 22,896 | Common Stock |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 292,500 | 292,500 | - | - | Stock Option (Right to Buy) | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 97,500 | 515,407 (1%) | 0% | 0 | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 46,250 | 362,699 (0%) | 0% | 0 | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 46,250 | 301,810 (0%) | 0% | 0 | Common Stock | |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 11 Jan 2022 | 5,100 | 417,907 (0%) | 0% | 2.5 | 12,546 | Common Stock |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 10 Jan 2022 | 22,727 | 28,313 (0%) | 0% | 0.1 | 3,409 | Common Stock |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 22,727 | 0 | - | - | Stock Option (right to buy) | |
| Nancy J. Hutson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Nancy J. Hutson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. | 29 Oct 2021 | 15,000 | 53,000 (0%) | 0% | 2.1 | 31,350 | Common Stock |
| Nancy J. Hutson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 29 Oct 2021 | 25,000 | 38,000 (0%) | 0% | 2 | 50,000 | Common Stock |
| Nancy J. Hutson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 6.46 per share. | 21 Sep 2021 | 3,525 | 423,007 (0%) | 0% | 6.5 | 22,772 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 21 Sep 2021 | 2,800 | 316,449 (0%) | 0% | 6.4 | 17,948 | Common Stock |
| Thomas Ciulla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 21 Sep 2021 | 2,560 | 255,560 (0%) | 0% | 6.4 | 16,384 | Common Stock |
| Nancy J. Hutson | Director | Purchase of securities on an exchange or from another person at price $ 5.68 per share. | 16 Aug 2021 | 3,000 | 13,000 (0%) | 0% | 5.7 | 17,040 | Common Stock |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 21 Jun 2021 | 3,707 | 426,532 (0%) | 0% | 4.4 | 16,237 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 21 Jun 2021 | 2,938 | 319,249 (0%) | 0% | 4.4 | 12,839 | Common Stock |
| Christy L. Shaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nancy J. Hutson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 19 Mar 2021 | 3,370 | 430,239 (0%) | 0% | 2.8 | 9,503 | Common Stock |
| Nancy J. Hutson | Director | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 12 Mar 2021 | 5,000 | 10,000 (0%) | 0% | 3.1 | 15,525 | Common Stock |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.37 per share. | 02 Mar 2021 | 6,000 | 433,609 (0%) | 0% | 3.4 | 20,220 | Common Stock |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Clay B. Thorp | Director | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Feb 2021 | 32,873 | 4,951,547 (11%) | 0% | 4.4 | 145,627 | Common Stock |
| Clay B. Thorp | Director | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Feb 2021 | 32,873 | 3,433,521 (7%) | 0% | 4.4 | 145,627 | Common Stock |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 284,750 | 284,750 | - | - | Stock Option (Right to Buy) | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 140,250 | 439,609 (0%) | 0% | 0 | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 195,640 | 195,640 | - | - | Stock Option (Right to Buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 96,360 | 322,187 (0%) | 0% | 0 | Common Stock | |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 209,375 | 209,375 | - | - | Stock Option (Right to Buy) | |
| Thomas Ciulla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 103,125 | 253,122 (0%) | 0% | 0 | Common Stock | |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 21 Dec 2020 | 3,330 | 299,359 (0%) | 0% | 2.1 | 6,893 | Common Stock |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 22 Sep 2020 | 13,411 | 302,689 (0%) | 0% | 1.6 | 21,323 | Common Stock |
| William D. Humphries | Director | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 18 Aug 2020 | 5,586 | 5,586 (0%) | 0% | 1.8 | 9,943 | Common Stock |
| Nancy J. Hutson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 01 Jun 2020 | 14,992 | 220,827 (0%) | 0% | 1.9 | 28,185 | Common Stock |
| Nancy J. Hutson | Director | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 20 May 2020 | 5,000 | 5,000 (0%) | 0% | 1.9 | 9,250 | Common Stock |
| George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 12 May 2020 | 32,150 | 311,100 (0%) | 0% | 2.0 | 63,979 | Common Stock |
| Nancy J. Hutson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2020 | 50,000 | 343,250 (0%) | 0% | 0 | Common Stock | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 66,250 | 288,250 (0%) | 0% | 0 | Common Stock | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 198,750 | 198,750 | - | - | Stock Option (Right to Buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 25,000 | 228,856 (0%) | 0% | 0 | Common Stock | |
| Clay B. Thorp | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.05 per share. | 22 Nov 2019 | 1,518,026 | 4,984,420 (11%) | 3% | 1.1 | 1,599,999 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 12 Nov 2019 | 7,500 | 203,856 (0%) | 0% | 1.1 | 8,550 | Common Stock |
| George M. Lasezkay | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 11 Nov 2019 | 12,000 | 222,000 (0%) | 0% | 1.2 | 13,920 | Common Stock |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 110,000 | 210,000 (0%) | 0% | 0 | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 70,000 | 196,356 (0%) | 0% | 0 | Common Stock | |
| George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2019 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Christy L. Shaffer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Edwards | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| William D. Humphries | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2019 | 50,000 | 126,356 (0%) | 0% | 0 | Common Stock | |
| Brion S. Raymond | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2019 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| George M. Lasezkay | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2019 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.36 per share. | 15 Mar 2019 | 10,000 | 76,356 (0%) | 0% | 1.4 | 13,600 | Common Stock |
| Daniel H. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Brion S. Raymond | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.36 per share. | 06 Dec 2018 | 8,000 | 8,000 (0%) | 0% | 1.4 | 10,880 | Common Stock |
| Jeffrey L. Edwards | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2018 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2018 | 8,618 | 0 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2018 | 2,632 | 0 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.81 per share. | 25 Jun 2018 | 8,618 | 77,513 (0%) | 0% | 8.8 | 75,925 | Common Stock |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.11 per share. | 25 Jun 2018 | 2,632 | 80,145 (0%) | 0% | 9.1 | 23,978 | Common Stock |
| Christy L. Shaffer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| George M. Lasezkay | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Evgeny Zaytsev | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| William D. Humphries | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2018 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 17 May 2018 | 61,139 | 3,466,394 (10%) | 0% | 13.2 | 804,589 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 17 May 2018 | 100,000 | 3,527,533 (11%) | 0% | 13.0 | 1,303,000 | Common Stock |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. | 11 May 2018 | 45,454 | 68,895 (0%) | 0% | 0.4 | 18,182 | Common Stock |
| Gerald D. Cagle | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2018 | 45,454 | 0 | - | - | Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Mar 2018 | 2,000 | 472,335 (1%) | 0% | 0 | Common Stock | |
| Daniel H. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.07 per share. | 28 Mar 2018 | 11,000 | 483,335 (1%) | 0% | 9.1 | 99,770 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.79 per share. | 23 Mar 2018 | 500 | 66,356 (0%) | 0% | 11.8 | 5,895 | Common Stock |
| Gerald D. Cagle | None | Purchase of securities on an exchange or from another person at price $ 11.89 per share. | 22 Mar 2018 | 7,500 | 23,441 (0%) | 0% | 11.9 | 89,175 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 21 Mar 2018 | 5,231 | 3,627,533 (11%) | 0% | 12.0 | 62,877 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.27 per share. | 21 Mar 2018 | 100,000 | 3,666,394 (11%) | 0% | 12.3 | 1,227,000 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 21 Mar 2018 | 33,630 | 3,632,764 (11%) | 0% | 12.1 | 405,914 | Common Stock |
| Brion S. Raymond | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2018 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Glenn Noronha | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2017 | 96,000 | 96,000 | - | - | Employee Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2017 | 221,500 | 221,500 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2017 | 96,000 | 96,000 | - | - | Employee Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 05 Dec 2017 | 5,000 | 3,766,394 (14%) | 0% | 6.1 | 30,650 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.37 per share. | 05 Dec 2017 | 15,000 | 3,786,394 (14%) | 0% | 6.4 | 95,550 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.09 per share. | 05 Dec 2017 | 15,000 | 3,771,394 (14%) | 0% | 6.1 | 91,350 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 14 Nov 2017 | 15,000 | 3,806,394 (15%) | 0% | 7.0 | 104,850 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 14 Nov 2017 | 5,000 | 3,801,394 (15%) | 0% | 7.0 | 34,950 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 14 Nov 2017 | 15,000 | 3,821,394 (15%) | 0% | 7.0 | 105,300 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 18 Oct 2017 | 3,600 | 477,935 (1%) | 0% | 7.8 | 28,152 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 18 Oct 2017 | 400 | 35,309 (0%) | 0% | 7.8 | 3,124 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 18 Oct 2017 | 3,600 | 474,335 (1%) | 0% | 7.8 | 28,116 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 18 Oct 2017 | 400 | 35,709 (0%) | 0% | 7.8 | 3,128 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 03 Oct 2017 | 6,000 | 3,836,394 (15%) | 0% | 8.3 | 50,040 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.64 per share. | 03 Oct 2017 | 15,000 | 3,856,394 (15%) | 0% | 8.6 | 129,600 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.59 per share. | 03 Oct 2017 | 14,000 | 3,842,394 (15%) | 0% | 8.6 | 120,260 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 13 Sep 2017 | 8,500 | 3,887,394 (15%) | 0% | 7.5 | 63,665 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 13 Sep 2017 | 10,000 | 3,871,394 (15%) | 0% | 7.5 | 75,400 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.52 per share. | 13 Sep 2017 | 6,000 | 3,881,394 (15%) | 0% | 7.5 | 45,120 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.53 per share. | 07 Sep 2017 | 9,000 | 486,935 (1%) | 0% | 7.5 | 67,770 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.63 per share. | 07 Sep 2017 | 5,400 | 481,535 (1%) | 0% | 7.6 | 41,202 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.53 per share. | 07 Sep 2017 | 1,000 | 36,709 (0%) | 0% | 7.5 | 7,530 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.63 per share. | 07 Sep 2017 | 600 | 36,109 (0%) | 0% | 7.6 | 4,578 | Common Stock |
| Christy L. Shaffer | None | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 15 Aug 2017 | 1,100 | 4,400 (0%) | 0% | 7 | 7,700 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.06 per share. | 14 Aug 2017 | 1,000 | 65,309 (0%) | 0% | 7.1 | 7,065 | Common Stock |
| Gerald D. Cagle | None | Purchase of securities on an exchange or from another person at price $ 7.08 per share. | 11 Aug 2017 | 5,000 | 15,941 (0%) | 0% | 7.1 | 35,400 | Common Stock |
| George M. Lasezkay | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.98 per share. | 07 Aug 2017 | 5,000 | 3,910,894 (15%) | 0% | 8.0 | 39,900 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.02 per share. | 07 Aug 2017 | 4,500 | 3,915,894 (15%) | 0% | 8.0 | 36,090 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.30 per share. | 07 Aug 2017 | 15,000 | 3,895,894 (15%) | 0% | 7.3 | 109,500 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.79 per share. | 19 Jul 2017 | 400 | 38,109 (0%) | 0% | 9.8 | 3,916 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 19 Jul 2017 | 400 | 37,709 (0%) | 0% | 9.7 | 3,884 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 19 Jul 2017 | 3,600 | 496,367 (1%) | 0% | 9.7 | 34,956 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.79 per share. | 19 Jul 2017 | 3,600 | 499,967 (1%) | 0% | 9.8 | 35,244 | Common Stock |
| Christy L. Shaffer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 7.74 per share. | 30 Jun 2017 | 3,100 | 503,567 (1%) | 0% | 7.7 | 23,994 | Common Stock |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 7.74 per share. | 30 Jun 2017 | 1,550 | 64,309 (0%) | 0% | 7.7 | 11,997 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Evgeny Zaytsev | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| William D. Humphries | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Derek Yoon | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,632 | 2,632 | - | - | Stock Option (right to buy) | |
| Christy L. Shaffer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Gerald D. Cagle | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Richard J. Croarkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Clay B. Thorp | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Evgeny Zaytsev | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| William D. Humphries | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Derek Yoon | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2017 | 8,618 | 8,618 | - | - | Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 13 Jun 2017 | 400 | 38,509 (0%) | 0% | 8.0 | 3,196 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 13 Jun 2017 | 400 | 38,909 (0%) | 0% | 7.8 | 3,112 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 13 Jun 2017 | 3,600 | 500,467 (1%) | 0% | 8.0 | 28,764 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 13 Jun 2017 | 3,600 | 504,067 (1%) | 0% | 7.8 | 28,008 | Common Stock |
| Christy L. Shaffer | None | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 23 May 2017 | 1,100 | 3,300 (0%) | 0% | 8 | 8,800 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 18 May 2017 | 9,000 | 3,935,394 (15%) | 0% | 8.4 | 75,960 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.31 per share. | 18 May 2017 | 15,000 | 3,920,394 (15%) | 0% | 8.3 | 124,650 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 17 May 2017 | 400 | 39,309 (0%) | 0% | 8.4 | 3,376 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.38 per share. | 17 May 2017 | 400 | 39,709 (0%) | 0% | 8.4 | 3,352 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 17 May 2017 | 3,600 | 507,667 (2%) | 0% | 8.4 | 30,384 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.38 per share. | 17 May 2017 | 3,600 | 511,267 (2%) | 0% | 8.4 | 30,168 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 15 May 2017 | 9,544 | 3,963,394 (15%) | 0% | 8.6 | 82,174 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 15 May 2017 | 15,941 | 3,972,938 (15%) | 0% | 8.9 | 142,513 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.39 per share. | 15 May 2017 | 19,000 | 3,944,394 (15%) | 0% | 8.4 | 159,410 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 17 Apr 2017 | 44,455 | 3,990,909 (15%) | 0% | 7.5 | 332,523 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.37 per share. | 17 Apr 2017 | 2,030 | 3,988,879 (15%) | 0% | 7.4 | 14,961 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 17 Apr 2017 | 22,000 | 4,035,364 (15%) | 0% | 7.4 | 163,460 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 03 Apr 2017 | 3,600 | 527,217 (2%) | 0% | 7.6 | 27,216 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 03 Apr 2017 | 400 | 40,109 (0%) | 0% | 7.5 | 3,016 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 03 Apr 2017 | 400 | 40,509 (0%) | 0% | 7.6 | 3,024 | Common Stock |
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 03 Apr 2017 | 3,600 | 523,617 (2%) | 0% | 7.5 | 27,144 | Common Stock |
| Gerald D. Cagle | None | Purchase of securities on an exchange or from another person at price $ 7.10 per share. | 27 Mar 2017 | 14,064 | 14,064 (0%) | 0% | 7.1 | 99,854 | Common Stock |
| Christy L. Shaffer | None | Purchase of securities on an exchange or from another person at price $ 6.90 per share. | 20 Mar 2017 | 2,200 | 2,200 (0%) | 0% | 6.9 | 15,180 | Common Stock |
| Gerald D. Cagle | None | Purchase of securities on an exchange or from another person at price $ 6.84 per share. | 16 Mar 2017 | 5,000 | 10,941 (0%) | 0% | 6.8 | 34,200 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 15 Mar 2017 | 47,000 | 4,078,849 (16%) | 0% | 6.5 | 304,090 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.77 per share. | 15 Mar 2017 | 21,485 | 4,057,364 (16%) | 0% | 6.8 | 145,453 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.55 per share. | 21 Feb 2017 | 25,000 | 4,127,849 (16%) | 0% | 7.6 | 188,750 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 21 Feb 2017 | 2,000 | 4,125,849 (16%) | 0% | 7.5 | 14,980 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 15 Feb 2017 | 17,485 | 4,176,849 (16%) | 0% | 7.6 | 133,585 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 15 Feb 2017 | 14,000 | 4,162,849 (16%) | 0% | 7.6 | 106,120 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 15 Feb 2017 | 10,000 | 4,152,849 (16%) | 0% | 7.5 | 75,400 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 17 Jan 2017 | 20,000 | 4,242,819 (17%) | 0% | 8.9 | 178,400 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.23 per share. | 17 Jan 2017 | 15,485 | 4,202,334 (17%) | 0% | 8.2 | 127,442 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.77 per share. | 17 Jan 2017 | 8,000 | 4,194,334 (17%) | 0% | 7.8 | 62,160 | Common Stock |
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.64 per share. | 17 Jan 2017 | 25,000 | 4,217,819 (17%) | 0% | 8.6 | 216,000 | Common Stock |
| Glenn Noronha | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 73,000 | 73,000 | - | - | Employee Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 238,000 | 238,000 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 96,000 | 96,000 | - | - | Employee Stock Option (right to buy) | |
| Glenn Noronha | Executive Vice President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Daniel H. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| Charles A. Deignan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 337,898 | 0 | - | - | Series C Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 689,388 | 0 | - | - | Series A-1 Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 1,598,219 | 1,654,242 | - | - | Common Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 1,598,223 | 1,654,248 | - | - | Common Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 2,035,907 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 19,900 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 432,941 | 0 | - | - | Series B Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 21,705 | 1,675,947 | - | - | Common Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 21,705 | 1,675,953 | - | - | Common Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 432,940 | 0 | - | - | Series B Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 2,035,908 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 21,705 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Kenneth B. Lee | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jun 2016 | 107,142 | 1,783,020 | - | - | Common Stock | |
| Kenneth B. Lee | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jun 2016 | 414,286 | 2,090,170 | - | - | Common Stock | |
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 689,388 | 0 | - | - | Series A-1 Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 1,805 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Kenneth B. Lee | Ten Percent Owner | 07 Jun 2016 | 337,897 | 0 | - | - | Series C Preferred Stock | ||
| Kenneth B. Lee | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 69 | 1,675,878 | - | - | Common Stock | |
| Kenneth B. Lee | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 69 | 1,675,884 | - | - | Common Stock | |
| Gerald D. Cagle | None | 07 Jun 2016 | 4,261 | 5,473 | - | - | Common Stock | ||
| Gerald D. Cagle | None | 07 Jun 2016 | 470 | 5,943 | - | - | Common Stock | ||
| Gerald D. Cagle | None | 07 Jun 2016 | 470 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Gerald D. Cagle | None | 07 Jun 2016 | 9,375 | 0 | - | - | Series B Preferred Stock | ||
| Gerald D. Cagle | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 2 | 5,941 | - | - | Common Stock | |
| Daniel H. White | Director, President and CEO | 07 Jun 2016 | 66,518 | 530,163 | - | - | Common Stock | ||
| Daniel H. White | Director, President and CEO | 07 Jun 2016 | 133,234 | 0 | - | - | Series A Preferred Stock | ||
| Daniel H. White | Director, President and CEO | 07 Jun 2016 | 657 | 530,820 | - | - | Common Stock | ||
| Daniel H. White | Director, President and CEO | 07 Jun 2016 | 657 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Daniel H. White | Director, President and CEO | 07 Jun 2016 | 13,110 | 0 | - | - | Series B Preferred Stock | ||
| Daniel H. White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 3 | 530,817 | - | - | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | 07 Jun 2016 | 470 | 62,761 | - | - | Common Stock | ||
| Charles A. Deignan | Chief Financial Officer | 07 Jun 2016 | 9,375 | 0 | - | - | Series B Preferred Stock | ||
| Charles A. Deignan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 2 | 62,759 | - | - | Common Stock | |
| Charles A. Deignan | Chief Financial Officer | 07 Jun 2016 | 4,261 | 62,291 | - | - | Common Stock | ||
| Charles A. Deignan | Chief Financial Officer | 07 Jun 2016 | 470 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 4,071,815 | 0 | - | - | Series A Preferred Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 19,900 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 43,410 | 3,477,243 | - | - | Common Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 1,654,531 | 0 | - | - | Series A-1 Preferred Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 1,805 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Clay B. Thorp | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 138 | 3,477,105 | - | - | Common Stock | |
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 675,795 | 0 | - | - | Series C Preferred Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 3,321,785 | 3,433,833 | - | - | Common Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 865,881 | 0 | - | - | Series B Preferred Stock | ||
| Clay B. Thorp | Director, Ten Percent Owner | 07 Jun 2016 | 21,705 | 0 | - | - | Warrant to Purchase Common Stock (right to buy) | ||
| Clay B. Thorp | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jun 2016 | 785,714 | 4,262,819 | - | - | Common Stock |